Skip to main content
Clinical Trials/NCT04871503
NCT04871503
Completed
Not Applicable

Simultaneous Application of High-Intensity Focused Electromagnetic Procedure and Radiofrequency for Toning of Buttocks

BTL Industries Ltd.5 sites in 1 country67 target enrollmentMarch 1, 2021
ConditionsMuscle Tone

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Muscle Tone
Sponsor
BTL Industries Ltd.
Enrollment
67
Locations
5
Primary Endpoint
The evaluation of change in adipose and muscle layer thickness.
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study will evaluate the clinical efficacy and safety of the BTL-899 device for toning of buttocks. The study is a prospective multi-center open-label two-arm study. The subjects will be enrolled and assigned into two study groups. The subjects will be enrolled and assigned into two study groups; HIFEM+RF (HR) and HIFEM (H) group. Subjects of both groups will be required to complete four (4) treatment visits and two follow-up visits.

Registry
clinicaltrials.gov
Start Date
March 1, 2021
End Date
January 12, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
BTL Industries Ltd.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \> 21 years
  • Voluntarily signed an informed consent form
  • BMI ≤ 35 kg/m2
  • Women of child-bearing potential are required to use birth control measures during the whole duration of the study
  • Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring during study participation
  • Subjects willing and able to maintain her regular (pre-procedure) diet and exercise regimen without affecting significant change in either direction during study participation

Exclusion Criteria

  • Electronic implants (such as cardiac pacemakers, defibrillators, and neurostimulators)
  • Metal implants
  • Drug pumps
  • Malignant tumor
  • Pulmonary insufficiency
  • Injured or otherwise impaired muscles
  • Cardiovascular diseases
  • Disturbance of temperature or pain perception
  • Hemorrhagic conditions
  • Septic conditions and empyema

Outcomes

Primary Outcomes

The evaluation of change in adipose and muscle layer thickness.

Time Frame: 4 months

The evaluation of change in adipose and muscle layer thickness between pre-treatment and post-treatment based on hip circumference measurements.

The evaluation of change in structure of subcutaneous tissues between pre-treatment and post-treatment based on MRI imaging in both study groups.

Time Frame: 4 months

The evaluation of structural changes of subcutaneous tissues between pre-treatment and post-treatment based on MRI imaging through measurements of the thickness of subcutaneous tissues

Secondary Outcomes

  • Patient's satisfaction with study treatment measured via questionnaires(4 months)
  • Evaluation of the Therapy's Safety Measured Via Therapy Comfort Questionnaire(4 months)

Study Sites (5)

Loading locations...

Similar Trials